Clinical Trial Update: Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an extended-release octreotide formulation (LF-PB) for treating lymphorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphorrhea

Drugs mentioned

• Octreotide (LF-PB) extended-release (octreotide)

Snippet

Sponsor: Chemi S.p.A. | Conditions: Lymphorrhea | Phase 2 | Status: COMPLETED